Cargando…
Update on oncolytic viral therapy – targeting angiogenesis
Oncolytic viruses (OVs) have the ability to selectively replicate in and lyse cancer cells. Angiogenesis is an essential requirement for tumor growth. Like OVs, the therapeutic effect of many angiogenesis inhibitors has been limited, leading to the development of more effective approaches to combine...
Autores principales: | Tysome, James R, Lemoine, Nick R, Wang, Yaohe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737009/ https://www.ncbi.nlm.nih.gov/pubmed/23940420 http://dx.doi.org/10.2147/OTT.S46974 |
Ejemplares similares
-
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010) -
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
por: Marelli, Giulia, et al.
Publicado: (2018) -
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
por: Ferguson, Mark S., et al.
Publicado: (2012) -
CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
por: Yuan, Ming, et al.
Publicado: (2016) -
Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
por: Howells, Anwen, et al.
Publicado: (2017)